[
    {
        "type": "text",
        "text": "地塞米松降解新基因的探讨",
        "text_level": 1,
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "张进¹，斯丹¹，杨致邦¹，熊玉霞¹，马廉举²，李津阳‘，蒋仁举 $^ 1 \\ast$ ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "1.重庆医科大学基础医学院病原生物学教研室重庆400016;  \n2.重庆医科大学药学实验教学中心重庆400016;  \n3.重庆医科大学临床医学2016级；",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "摘要目的探讨地塞米松降解代谢新基因，为构建高效、稳定的地塞米松降解基因工程菌提供思路。方法根据新发现的地塞米松降解菌 Burkholderia sp.CQ001（B.CQ001）全基因组测序和生物信息学分析，筛选疑似与地塞米松代谢相关基因。提取B.CQ001总RNA逆转录为cDNA,以cDNA为模板,利用 PCR技术快速克隆经实时荧光定量PCR 技术(RT-qPCR)验证筛选出的新基因，测序鉴定后连接原核表达载体pET-28a- $\\cdot \\mathrm { c } ( + )$ ，构建重组质粒pET-28a-Ivd。将pET-28a-Ivd 转化感受态 Burkholderia sp.CQ001，高效液相色谱(HPLC)验证表达菌降解能力的提升。结果从B.CQ001基因组中筛选出3个未知基因分别为：ORF05499，ORF05827，ORF06535，其表达产物分别为：过氧化物还原酶，甾酮异构酶，异戊酰辅酶A脱氢酶；实时荧光定量PCR分析显示，3个目的基因在地塞米松诱导后均有不同程度表达上调，基因ORF06535表达上调明显；在B.CQ001中过表达基因ORF06535，HPLC 检测显示，表达菌对地塞米松磷酸钠和地塞米松的降解率可达到 $89 . 0 \\%$ 和 $80 . 0 \\%$ ，相比原菌 B.CQ001有明显提升。结论在B.CQ001中发现新的地塞米松降解相关基因ORF06535，并完成基因克隆和功能验证，为制备地塞米松以及甾体激素污染的生物修复剂提供了新的基因信息。",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "关键词：伯克霍尔德菌；地塞米松；降解；基因；RT-qPCR张进，斯丹为共同第一作者，通讯作者：蒋仁举张进：邮箱：yinghangz@126.com 15310095725蒋仁举：邮箱：743322835@qq.com 13883970998",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Study on New Genes associated with Dexamethasone Degradation ",
        "text_level": 1,
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "ZHANG Jin1， SI Dan1，YANG Zhi-bangl，XIONG Yu-xia1，MA Lian-ju²，LI Jin-yang³，JIANG Ren-jul\\* ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "(DepartmentofPathogenic Biology，CenterofPharmacyExperimentalTeaching，Clinical MedicalCollge，Chongqing Medical University，Chongqing，400016，China) ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Abstract Ob jective To investigate the new genes associated with dexamethasone metabolism in order to provide an idea for the construction of an efficient and stable dexamethasone degrading engineering bacterium. MethodsTarget genes which were suspectly associated with dexamethasone metabolism were screened according to the results of the whole genome sequencing and bioinformatics analysis of the newly discovered dexamethasone degrading bacteria Burkholderia sp.CQ001 (B.CQ001). Total RNA of B.CQ001 was extracted from B.CQ00l was processed by RT-PCR to produce cDNA. Using cDNA as a template, the new gene was rapidly cloned subsequently by PCR technology which was verified by real-time fluorescence quantitative PCR (RT-qPCR), then connected with prokaryotic expression vector pET-28a-c $( + )$ ,after DNA sequencing. The recombinant plasmid pET-28a-Ivd was transformed into Burkholderia sp.CQo01. Using high performance liquid chromatography (HPLC) to evaluate the biodegradability of the expressed bacteria for dexmethasone sodium phosphate. Results Three unknown genes were screened out from B.CQ001: ORF05499, ORF05827, ORF06535, and their expressed products were: peroxiredoxin, Ketosteroid isomerase, isovaleryl coenzyme A dehydrogenase; Real time quantitative PCR analysis showed that the expression levels of three genes were upregulated in different degrees after induced by dexamethasone ,especially gene ORF06535; HPLC showed that the degradation of dexamethasone sodium phosphate and dexamethasone rate can reach to $89 \\%$ and $80 \\%$ after overexpression of ORF06535 in B.CQ001. Compared with the original strain B.CQoo1, the degradation ability had improved significantly. Conclusion New gene ORFo6535 associated with dexamethasone degradation was discovered in B.CQool which had been cloned and functional verified. It provides new genetic information for preparation of dexamethasone and steroid hormone bioremediation. ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Keywords: Burkholderia； Dexamethasone；Degradation；Gene； RT-qPCR",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "伯克霍尔德菌属（Burkholderia）的细菌因其16SrRNA基因序列，DNA/DNA同源性、细胞类脂和脂肪的特性于1992年从假单胞菌属的PalleronirRNA同源群中划分出来成为独立的属[。该菌属的细菌广泛存在于自然环境中。近年来文献报道，伯克霍尔德菌具有非常独特的代谢能力，能以200多种有机物作为碳源、氮源和能源进行生长繁殖[2]，在环境保护研究中受到了越来越多研究者的青睐，被应用于生物修复技术中降解难以处理的外源性污染物，被冠以“环保卫士”的称号。其中，典型的代表菌株如B.vietnamiensis strainG4，它能降解地表水及地下水中具有生物毒性和致癌性的三氯乙烯（TCE)，其全基因组信息已经公布[3],但尚未见该菌属的细菌能够降解甾体类激素的报道。",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "地塞米松类药物是国内外广泛应用的甾体激素[4，常用于临床各科多种疾病的治疗，如自身免疫性疾病[5]，皮肤病[6]，炎症[7]，哮喘[8]等。常用的地塞米松制剂为易溶于水的地塞米松磷酸钠。地塞米松类药物在应用过程中，其药物残液可经各种途径污染环境，特别是医院废水。国内外多篇文献报道在废水厂处理后的废水和江、河水中存在地塞米松等糖皮质类激素污染[9-12]。动物实验证实，地塞米松可引起兔的胎儿发育迟缓和上颚腭裂[13]，使斑马鱼头部骨骼产生骨质疏松[14]。给BALB/c小鼠饲喂含高、中、低污染量地塞米松磷酸钠的饮用水，对小鼠神经系统均有明显的影响，可抑制肠道益生菌的定植，有利于肠道致病菌的入侵[15]。环境中的激素可通过食物链的传递和生物蓄积作用对生物和人类健康造成严重影响。因此清除地塞米松类药物的医源性污染对保护生态环境具有重要的实际意义。",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "本研究在前期工作中，从医院废水中分离到一株伯克霍尔德氏菌属的细菌Burkholderia sp.CQ001，并首次发现该菌具有降解地塞米松的功能。通过对其全基因组测序，成功构建该菌基因组文库。为深入了解地塞米松降解相关基因及其降解机制，通过生物信息学分析，从该菌的未知基因中筛选出疑似与地塞米松降解相关基因，通过RT-qPCR和克隆表达验证，为深入了解地塞米松降解相关基因及其降解机制，构建高效降解工程菌，制备清除环境中地塞米松类药物污染的生物净化剂提供基因信息。",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "1材料",
        "text_level": 1,
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "1.1菌株 ",
        "text_level": 1,
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "伯克霍尔德菌CQ001（Burkholderia sp.CQ001)：从中国重庆市某医院净化处理前的污水处理池废水中分离，16SrDNA测序鉴定，命名为Burkholderiasp.CQ001（B.CQ001)。该菌经驯化后对地塞米松磷酸钠及地塞米松的总降解率分别为 $84 . 8 \\%$ 和 $7 7 . 1 1 \\%$ 。目前该菌全基因组测序已完成，BioProject Accession:PRJNA329146[16]。实验用大肠杆菌菌株Escherichiacoli $D H 5 a$ 由本实验室保藏。",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "1.2主要培养基",
        "text_level": 1,
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "LB 固体培养基为重庆泽恒生物售品；缺碳培养液（ $1 0 0 0 \\mathrm { m L }$ ） $\\mathrm { K _ { 2 } H P O _ { 4 } } 1 . 6 \\mathrm { g }$ $\\mathrm { K H _ { 2 } P O _ { 4 } 0 . 4 g }$ ， $\\mathrm { M g S O _ { 4 } } { \\cdot } 7 \\mathrm { H _ { 2 } O } 0 . 2 \\mathrm { g }$ ， $\\mathrm { N a C l 0 . l g }$ ， $( \\mathrm { N H _ { 4 } } ) _ { 2 } \\mathrm { S O _ { 4 } } 0 . 5 \\mathrm { g }$ ，为本实验室配制；地塞米松磷酸钠原液（ $5 \\mathrm { m g / m L }$ ： $2 0 0 \\mathrm { m L }$ 无菌 $\\mathrm { \\ d d H } _ { 2 } \\mathrm { O }$ 充分溶解 $1 . 0 \\mathrm { g }$ 地塞米松磷酸钠后 $4 ^ { \\circ } \\mathrm { C }$ 避光储存备用；地塞米松磷酸钠培养液（ $5 0 0 \\mathrm { n g / m L }$ ： $9 \\mathrm { m L }$ 缺碳培养液中加入 $\\mathrm { 1 m L 5 m g / m L }$ 地塞米松磷酸钠原液，于使用前配制；蔗糖无机盐液体培养基（ $1 0 0 0 \\mathrm { m L } \\cdot$ )：缺碳培养液 $1 0 0 0 \\mathrm { m L }$ 加入蔗糖 $3 . 0 \\mathrm { g }$ ，于使用前配制。",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "1.3其它主要的实验材料",
        "text_level": 1,
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "RNAprepPure培养细胞/细菌总RNA提取试剂盒（天根，北京）;PrimeScript $^ \\mathrm { T M } \\mathrm { R T }$ reagent Kit with gDNA Eraser（TaKaRa， 大连)；pUCm-T VectorCloningKit（生工，上海）； $\\mathrm { p E T - } 2 8 \\mathrm { a } ( + )$ 表达载体为重庆医科大学附属第一医院脂糖代谢实验室惠赠；质粒DNA 提取试剂盒（OMEGA，美国)；MiniBESTAgaroseGelDNAExtractionKit（TaKaRa，大连)；限制性核酸内切酶NotI、BamHI（NEB,美国)；其它试剂均为进口或国产分析纯。",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "2方法",
        "text_level": 1,
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "2.1地塞米松降解相关基因的挖掘 ",
        "text_level": 1,
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "根据B.CQ001 基因组测序结果，BioProject Accession：PRJNA329146,BioSample:SAMN05417702，ID:5417702。针对该菌基因组中429个未被分类的基因，利用NCBIBLASTX2.6.1预测其表达蛋白与功能。选取：与表达甾体代谢相关类酶同源性较高；与目前文献报道的甾体降解相关基因距离较近的基因（基因测序ORF编号距离 $< 2 0$ ，且基因序列长度 $> 1 0 0 \\mathsf { b p }$ ）°",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "2.2目的基因的生物信息学分析",
        "text_level": 1,
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "将筛选的目的基因序列采用DNAMAN和NCBI（NationalCenter forBiotechnology Information，http://www.ncbi.nlm.nih.gov/）网站上 Blast N 和 BlastX 进行翻译产物预测。利用蛋白质分析系统EXPASYProteomic（http://www.expasy.org/proteomics）中的蛋白质在线分析软件Protparam(http://web.expasy.org/protparam/）结合Compute PI/Mw 对3 个未知基因编码氨基酸序列进行基本理化性质分析；利用 ProtScale(http://web.expasy.org/protscale/)进行预测蛋白亲/疏水性分析；利用 SOSUI（http://harrier.nagahama-i-bio.ac.jp/sosui/sosui_submit.html）进行预测蛋白可溶性分析；利用PSORTb3.0.2（http://www.psort.org/psortb/）进行亚细胞定位分析；利用TMHMM server v2.0（http://www.cbs.dtu.dk/services/TMHMM/）进行跨膜结构分析；利用 SignalP 4.1Server（http://www.cbs.dtu.dk/services/SignalP/）进行信号肽分析；利用 NCBI 的Conserved Domains (https://www.ncbi.nlm.nih.gov/cdd/?term $\\vDash$ ）进行保守结构域和功能域分析;利用在线工具 SOPMA(https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_sopma.html）进行二级结构预测；利用 SWISS-MODEL（http://swissmodel.expasy.org/）进行同源三维建模。",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "2.3RT-qPCR验证目的基因 ",
        "text_level": 1,
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "实验分为诱导组和对照组。诱导组将B.CQ001接种于地塞米松磷酸钠培养液，对照组接种于蔗糖无机盐培养液，置 $3 7 ^ { \\circ } \\mathrm { C } , 2 0 0 \\mathrm { r / m i n }$ 震荡培养，按照RNAprepPure 培养细胞/细菌总RNA 提取试剂盒说明提取总RNA。以约 $5 0 0 \\mathrm { n g }$ 总RNA作为模板，逆转录合成cDNA[17]。以rpoA为内参，cDNA为模板，验证B.CQ001在两种不同培养环境下前期筛选出的3个未知基因在转录水平上的表达变化。基因qPCR引物见表1。反应体系（ $\\mathrm { 1 0 u L } )$ :SYBR Premix ${ 5 . 0 } \\mathrm { u L }$ 、上下游引物（10umol/L）各 $0 . 4 \\mathrm { u L }$ 、cDNA 溶液 $1 . 0 \\mathrm { u L }$ 、无酶 $\\mathrm { d d H } _ { 2 } \\mathrm { O } 3 . 2 \\mathrm { u L }$ 。反应条件： $9 5 ^ { \\circ } \\mathrm { C }$ 预变性30s； $9 5 ^ { \\circ } \\mathrm { C }$ 变性5s， $6 0 ^ { \\circ } \\mathrm { C }$ 退火及延伸30s，共40个循环；熔解曲线阶段： $6 5 ^ { \\circ } \\mathrm { C }$ 到 $9 5 ^ { \\circ } \\mathrm { C }$ 。根据 RT-qPCR 反应后得到的各样本Ct值，采用 $2 ^ { - \\Delta \\Delta \\mathrm { C t } }$ 法（ $\\Delta C t = \\mathrm { C t }$ 目的基$\\mathrm { \\Phi _ { \\vert \\mathcal { K } \\vert } - C t _ { r p o A } }$ ， $\\Delta \\Delta \\mathrm { C t = C t _ { \\partial \\hat { \\eta } \\in \\dot { \\mathbb { Z } } \\times \\hat { \\mathbb { C } } \\times \\hat { \\mathbb { C } } \\times \\hat { \\mathbb { Z } } \\times \\hat { \\mathbb { Z } } } } )$ 进行计算。",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "表1Burkholderiasp.CQ0013个未知基因实时荧光定量PCR引物",
        "text_level": 1,
        "page_idx": 5
    },
    {
        "type": "table",
        "img_path": "images/bc3b681ebaf7b1c8690c0c3ced06c8dc7e1bc0a4c346bbe8cbce71388144b1bf.jpg",
        "table_caption": [
            "Tablel Real-time PCR primers of three unknown genes from Burkholderia sp.CQ001 "
        ],
        "table_footnote": [],
        "table_body": "<html><body><table><tr><td>引物名称Primer</td><td>序列Primer sequences</td></tr><tr><td>rpoA</td><td>Forward 5'- GATCTGAACGTCGAGCTTGC-3'</td></tr><tr><td>Reverse</td><td>5'-AAGGAAGGTGAAGGCGTTGT - 3'</td></tr><tr><td>ORF05499 Forward</td><td>5'-ACATGGTGCAGAACGAAGC- 3'</td></tr><tr><td>Reverse</td><td>5'- AGTACGCAATACGCATCGAA- 3'</td></tr><tr><td>ORF05827 Forward</td><td>5' - CGCAGGATTTTTCATTGACG - 3'</td></tr><tr><td>Reverse</td><td>5'- GATCCGGTTGACCACCATC - 3'</td></tr><tr><td>ORF06535</td><td>5'- CAATTCATGCTCGGTGAAGA - 3'</td></tr><tr><td>Forward Reverse</td><td>5' - CAGATCCATCGGAAACTGGT- 3'</td></tr></table></body></html>",
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "2.4PCR扩增0RF06535基因 ",
        "text_level": 1,
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "选择实时荧光定量PCR验证经地塞米松诱导后表达升高明显的ORF06535基因，用PrimerPremier 6.0 和DNAstar 设计扩增引物。上游引物序列为：5'-ATGATCAACCTGCCCGGT-3'，下游引物序列为:5' - TTACATCGTTTCCGCGAAC-3'，提交生工合成。以B.CQ001cDNA为模板，进行PCR 扩增。反应体系：cDNA 2uL，上、下游引物（20umol/L）各 $0 . 5 \\mathrm { u L }$ ，Taq mix 10uL，无菌 $\\mathrm { d d H } _ { 2 } \\mathrm { O } 7 \\mathrm { u L }$ 总体积 $2 0 \\mathrm { u L }$ 。反应程序： $9 4 ^ { \\circ } \\mathrm { C }$ 预变性 $3 \\mathrm { m i n }$ ， $9 4 ^ { \\circ } \\mathrm { C }$ 变性30s， $5 2 ^ { \\circ } \\mathrm { C }$ 退火30s， $7 2 ^ { \\circ } \\mathrm { C }$ 延伸1min，30个循环后， $7 2 ^ { \\circ } \\mathrm { C }$ 延伸 $5 \\mathrm { m i n }$ 。取5uL扩增产物 $1 \\%$ 琼脂糖凝胶电泳，电泳结果在凝胶成像仪下观察并拍照。",
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "2.50RF06535克隆",
        "text_level": 1,
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "因基因ORF06535表达蛋白：异戊酰辅酶A脱氢酶，故后简称该基因为：Ivd。按照TaKaRa胶回收试剂盒说明回收基因ORF06535PCR产物并纯化，连接pUCm-T载体，热激转化大肠杆菌 $\\mathrm { D H } 5 \\mathrm { a }$ 感受态， $3 7 ^ { \\circ } \\mathrm { C } 1 2 0 \\mathrm { r p m / m i n }$ 复苏培养1h。取 ${ 5 0 } \\mathrm { u L }$ 接种于含 IPTG、X-Gal 和 Amp（ $\\mathrm { \\cdot 1 0 0 u g / m L }$ ）的LB平板， $3 7 ^ { \\circ } \\mathrm { C }$ 培养过夜后筛选阳性克隆。经质粒PCR和双酶切初步鉴定后送生工测序。经鉴定阳性重组质粒命名为pUCm-Ivd。",
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "2.6重组质粒pET-28a-Ivd构建 ",
        "text_level": 1,
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "将克隆质粒pUCm-Ivd与表达载体pET-28a- $\\cdot \\mathrm { c } ( + )$ 分别用BamHI和NotI双酶切后，切胶回收酶切片段，加入T4DNA连接酶 $1 6 ^ { \\circ } \\mathrm { C }$ 连接过夜。连接产物转化氯化钙法制备的感受态细胞B.CQ001，取 $2 0 0 \\mathrm { u L }$ 接种于含Kana（ ${ 5 0 } \\mathrm { u g / m L }$ ）的LB平板， $3 7 ^ { \\circ } \\mathrm { C }$ 培养过夜后筛选阳性克隆表达菌，经质粒PCR和双酶切初步鉴定，送生工测序。经鉴定阳性重组质粒命名为pET-28a-Ivd。",
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "2.7目的基因表达验证 ",
        "text_level": 1,
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "转化有pET-28a-Ivd的阳性克隆表达菌命名为：B.CQ002，将表达菌与驯化冻存菌 B.CQ001，参照石中全等[18]的方法，挑取单菌落接种于 $1 0 \\mathrm { m L } 5 0 0 \\mathrm { u g / m L }$ 的地塞米松磷酸钠培养液，置 $3 7 ^ { \\circ } \\mathrm { C }$ ， $2 0 0 \\mathrm { r / m i n }$ 震荡培养10天，于培养的不同时间点（0h，2h，4h，8h，12h，24h，48h，72h，96h，120h，144h，168h，192h,240h）用高效液相色谱法（HPLC）检测表达菌和驯化冻存菌对地塞米松磷酸钠及地塞米松的降解能力和降解高峰时间。",
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "2.8统计学分析",
        "text_level": 1,
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "采用 SPSS22.0软件对实验数据进行统计分析。采用配对t检验分析3个目的基因地塞米松诱导组和蔗糖无机盐对照组在转录水平上的表达变化和B.CQ001和B.CQ002对地塞米松磷酸钠及地塞米松的降解作用差异。",
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "3结果",
        "text_level": 1,
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "3.1地塞米松降解相关基因的挖掘 ",
        "text_level": 1,
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "从B.CQ001众多未知基因中筛选出3个基因，分别为：ORF05499,ORF05827，ORF06535，均来自该菌集中了大部分代谢功能基因的2号染色体。3个目的基因的长度和选择依据见表2，基因簇排列情况见图1，基因位置见图2。目的基因ORF05499与文献报道的甾体代谢基因 $3 \\beta$ -羟基甾体脱氢酶/异构酶（ $3 \\beta$ -HSD)距离较近（基因测序ORF编号距离 $= 1 0$ )，且与课题组前期验证的地塞米松摄取转运基因ABC转运子距离接近（基因测序ORF编号距离 $^ { - 1 1 }$ )；目的基因ORF05827经NCBIBLASTX2.6.1预测表达蛋白为甾酮异构酶；目的基因ORF06535表达氨基酸序列与课题组前期从一株产碱假单胞菌中分离到的具有地塞米松降解活性的41kD蛋白经质谱鉴定得到的5条肽段序列相似性较高(Querycover: $33 \\%$ ，Ident: $54 \\%$ ）[19]（图3）。",
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "表2待验证的Burkholderiasp.CQ0013个未知基因",
        "text_level": 1,
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "Table2 Three unknown genes to be validated from Burkholderia sp.CQ001 ",
        "page_idx": 7
    },
    {
        "type": "table",
        "img_path": "images/93035c8a44768805139bb3765bc1d9216e0245f30f14310951db4f7ae2bc4e7a.jpg",
        "table_caption": [],
        "table_footnote": [],
        "table_body": "<html><body><table><tr><td>目的基因</td><td>基因位置</td><td>序列长度（bp）</td><td>选择依据</td></tr><tr><td>ORF05499</td><td>2号染色体</td><td>468bp</td><td>与甾体代谢基因3β-HSD，ABC 转运子距离接近</td></tr><tr><td>ORF05827</td><td>2号染色体</td><td>474bp</td><td>表达甾体代谢相关类酶：甾酮异构酶</td></tr><tr><td>ORF06535</td><td>2号染色体</td><td>1182bp</td><td>课题组前期发现地塞米松降解相关蛋白41kD</td></tr></table></body></html>",
        "page_idx": 7
    },
    {
        "type": "image",
        "img_path": "images/903d7e84eec116bb1dd1b898cbb8cc9a1501f14b62f867bbd237050a35a94cb1.jpg",
        "img_caption": [
            "基因ORF05499"
        ],
        "img_footnote": [],
        "page_idx": 7
    },
    {
        "type": "image",
        "img_path": "images/c89f3ee49c9f4fffac295797a7ac1ec4013a3110bb9a91bc8d969f5744902de8.jpg",
        "img_caption": [
            "基因ORF05827"
        ],
        "img_footnote": [],
        "page_idx": 7
    },
    {
        "type": "image",
        "img_path": "images/26bf30a7fdf32f425c5cc01b0ca17f8ffee50aa7eae215bad82b0a1eb17b2cc4.jpg",
        "img_caption": [
            "图1待验证的Burkholderiasp.CQ0013个未知基因基因簇排列情况"
        ],
        "img_footnote": [],
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "Fig.1 The arrangement of 3 unknown gene clusters in Burkholderia sp.CQo0l to be verified ",
        "page_idx": 7
    },
    {
        "type": "image",
        "img_path": "images/bb65d5316311f9100e62bca62356a2f417e1ca5734442efade15b7aedb211c8f.jpg",
        "img_caption": [
            "图2待验证的Burkholderiasp.CQ0013个未知基因基因位置图"
        ],
        "img_footnote": [],
        "page_idx": 8
    },
    {
        "type": "image",
        "img_path": "images/9f084d451f7dd2e8773f0952c8ad2f4e034baeb9257624059ffee27b86a31f36.jpg",
        "img_caption": [
            "Fig.2 The location map of 3 unknown genes in Burkholderia sp.CQ001 ",
            "图3目的基因0RF06535氨基酸序列与降解相关蛋白41kD5条肽段氨基酸序列比对结果"
        ],
        "img_footnote": [],
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "Fig.3 The sequence alignment result of ORF06535 amino acid sequence and 5 peptides from 41kD ",
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "degradation protein ",
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "3.2目的基因生物信息学分析",
        "text_level": 1,
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "表3待验证的Burkholderia sp.CQ0013个未知基因生物信息学分析结果",
        "text_level": 1,
        "page_idx": 9
    },
    {
        "type": "table",
        "img_path": "images/fe9772abcf3a815eb85f09b0504b2569613b2950849eb0b6571dd6468f20cce3.jpg",
        "table_caption": [
            "Table3 Bioinformatics analysis results of 3 unknown genes from Burkholderia sp.CQ001 "
        ],
        "table_footnote": [],
        "table_body": "<html><body><table><tr><td colspan=\"4\"></td></tr><tr><td>基因名称</td><td>ORF05499</td><td>ORF05827</td><td>ORF06535</td></tr><tr><td>基因长度(bp)</td><td>468bp</td><td>474bp</td><td>1182bp</td></tr><tr><td>理化性质</td><td></td><td></td><td></td></tr><tr><td>氨基酸数</td><td>155</td><td>157</td><td>393</td></tr><tr><td>分子式</td><td>C722H1148N198O222S8</td><td>C817H1260N250O224S6</td><td>C1887H2996N524O569S24</td></tr><tr><td>相对分子质量(Mr)</td><td>16410</td><td>18360</td><td>42897</td></tr><tr><td>理论等电点(pl)</td><td>4.57</td><td>9.98</td><td>5.71</td></tr><tr><td>不稳定系数</td><td>26.17（稳定）</td><td>24.47（稳定）</td><td>30.23（稳定）</td></tr><tr><td>亲/疏水性(GRAVY)</td><td>0.270（疏水）</td><td>-0.466（亲水）</td><td>-0.126（亲水）</td></tr><tr><td>预测蛋白</td><td>过氧化物还原酶</td><td>甾酮异构酶</td><td>异戊酰辅酶A脱氢酶</td></tr><tr><td>可溶性</td><td>可溶蛋白</td><td>可溶蛋白</td><td>可溶蛋白</td></tr><tr><td>亚细胞定位</td><td>未知</td><td>未知</td><td>细胞质</td></tr><tr><td>跨膜区</td><td>无跨膜(膜内)</td><td>无跨膜(膜内)</td><td>无跨膜 (膜内)</td></tr><tr><td>信号肽</td><td>无</td><td>无</td><td>无</td></tr><tr><td>保守结构域</td><td>OsmC 结构域</td><td>Snoal-like 结构域</td><td>Acyl-CoA.dh.N</td></tr><tr><td></td><td>氧化应激调节</td><td>甾酮分子异构化</td><td>物质分解代谢</td></tr><tr><td>二级结构</td><td>α-螺旋(40.65%)</td><td>α-螺旋(63.69%)</td><td>α-螺旋(40.20%)</td></tr><tr><td></td><td>β-折叠(10.97%)</td><td>β-折叠(4.46%)</td><td>β-折叠(13.23%)</td></tr><tr><td></td><td>延伸链(25.16%)</td><td>延伸链(12.74%)</td><td>延伸链(22.65%)</td></tr><tr><td></td><td>无规则卷曲(23.23%)</td><td>无规则卷曲(19.11%)</td><td>无规则卷曲(23.92%)</td></tr><tr><td></td><td></td><td></td><td></td></tr></table></body></html>",
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "3.3地塞米松对目的基因表达的影响 ",
        "text_level": 1,
        "page_idx": 9
    },
    {
        "type": "text",
        "text": "为了探究3个未知基因在地塞米松降解过程中起到的作用，通过RT-qPCR检测3个目的基因地塞米松诱导后的表达情况。结果显示，3个基因在以地塞米松为唯一碳源和能源的诱导条件下表达均有上调，和蔗糖无机盐对照组相比差异具有统计学意义 $( \\mathbf { P } < 0 . 0 5 )$ 。其中，诱导组ORF06535表达水平显著高于对照组，提示ORF06535可能是B.CQ001代谢地塞米松机制中的一个关键基因，对于地塞米松降解具有特殊作用（图4)。",
        "page_idx": 9
    },
    {
        "type": "image",
        "img_path": "images/451cc3c5cba40c3a3a29fc06517a66486ab20c56ce40edbdc3ae3d51deb90948.jpg",
        "img_caption": [
            "图4RT-qPCR技术验证地塞米松诱导组和蔗糖无机盐对照组3个基因差异表达"
        ],
        "img_footnote": [],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Fig.4 Different expression levels of 3 genes between dexamethasone induced group and sucrose inorganic salt control group ",
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "3.4PCR扩增0RF06535基因 ",
        "text_level": 1,
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "PCR产物经 $1 \\%$ 琼脂糖凝胶电泳分析，可见在1100bp左右有一条带，大小与预期一致，见图5。提交上海生工测序。测序结果显示，基因序列与基因ORF06535序列一致。",
        "page_idx": 10
    },
    {
        "type": "image",
        "img_path": "images/ddbca2bf3758eee5312a39fc25449e28f8e160d3c44d948244885d7759ee2058.jpg",
        "img_caption": [
            "图5基因ORF06535PCR产物的琼脂糖凝胶电泳结果"
        ],
        "img_footnote": [],
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "Fig.5 Agarose gel electrophoresis result of gene ORF06535 PCR products ",
        "page_idx": 10
    },
    {
        "type": "text",
        "text": "3.5目的基因0RF06535克隆",
        "text_level": 1,
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "重组质粒pUCm-Ivd转化E.ColiDH5α后，经PCR和双酶切鉴定确有插入片段，见图6。测序结果显示，插入的基因片段全长1182bp，与预期一致。",
        "page_idx": 11
    },
    {
        "type": "image",
        "img_path": "images/c7dd97eb33dd3c0d697027ce4347c656e922f034fd86252feeec9b91604a7208.jpg",
        "img_caption": [
            "图6pUCm-Ivd琼脂糖凝胶电泳结果"
        ],
        "img_footnote": [],
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "3.6重组质粒pET-28a-Ivd构建 ",
        "text_level": 1,
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "重组质粒pET-28a-Ivd转化感受态B.CQ001后，经PCR及双酶切鉴定确有插入片段，见图7。测序结果显示，插入的基因片段全长1182bp，与预期一致。",
        "page_idx": 11
    },
    {
        "type": "image",
        "img_path": "images/82a6365232a23a2d7a084569b9994902f03861ea4201231e9cb4d14e56e00ce8.jpg",
        "img_caption": [
            "Fig.6 Agarose gel electrophoresis result of pUCm-Ivd "
        ],
        "img_footnote": [],
        "page_idx": 11
    },
    {
        "type": "text",
        "text": "4:pET-28a-Ivd/BamHI+NotI双酶切验证   \n5:DNA markerDL15000   \n1:DNAMarkerDL2000   \n2:PCR validation of pET-28a-Ivd   \n3:pET-28a-Ivd   \n4 :Double enzyme digestion assay of pET-28a-Ivd/BamHI+NotI   \n5 :DNA marker DL15000 ",
        "page_idx": 12
    },
    {
        "type": "text",
        "text": "Fig.7 Agarose gel electrophoresis result of pET-28a-Ivd ",
        "page_idx": 12
    },
    {
        "type": "text",
        "text": "3.7目的基因表达验证 ",
        "text_level": 1,
        "page_idx": 12
    },
    {
        "type": "text",
        "text": "HPLC 结果显示，驯化冻存菌B.CQ001和表达菌B.CQ002均能将地塞米松磷酸钠先降解为地塞米松再降解为其他小分子物质（图8)。相比驯化冻存菌B.CQ001，表达菌 B.CQ002 降解高峰出现的时间无明显改变，但对地塞米松磷酸钠的10天累计总降解率从B.CQ001的 $80 . 5 \\%$ 升高到 $89 . 0 \\%$ （图9-a)；对地塞米松的10天累计总降解率从B.CQ001的 $71 . 5 \\%$ 升高到 $80 . 0 \\%$ （图9-b)。SPSS 统计分析驯化冻存菌B.CQ001和表达菌B.CQ002对地塞米松磷酸钠及地塞米松的降解能力差异有统计学意义。（ $\\left( \\mathbf { P } < 0 . 0 5 \\right)$ （204号",
        "page_idx": 12
    },
    {
        "type": "image",
        "img_path": "images/a11e7056f156b9ae6da7e1967a12b3d156e9302e2c0ff17019b80934d94bb6a2.jpg",
        "img_caption": [
            "图7pET-28a-Ivd琼脂糖凝胶电泳结果",
            "驯化冻存菌B.CQ001 "
        ],
        "img_footnote": [],
        "page_idx": 12
    },
    {
        "type": "image",
        "img_path": "images/90f78b9e256263615d1495cc3087438b518bdcaa09ef85c4d2f3c04dc2957c9f.jpg",
        "img_caption": [
            "表达菌B.CQ002",
            "图8驯化冻存菌B.CQ001和表达菌B.CQ002降解过程HPLC色谱图"
        ],
        "img_footnote": [],
        "page_idx": 13
    },
    {
        "type": "image",
        "img_path": "images/cdbd04d43c4e1e7d21cfe96031689b421fec9d42cb12591c8bd000746d4fb890.jpg",
        "img_caption": [
            "Fig.8 Degradation process HPLC chromatogram map of B.CQ001 and B.CQ002 ",
            "图9B.CQ001和B.CQ002地塞米松磷酸钠和地塞米松的降解曲线"
        ],
        "img_footnote": [],
        "page_idx": 13
    },
    {
        "type": "text",
        "text": "Fig.9 Degradation curves of B.CQo01 and B.CQo02 dexamethasone sodium phosphate and ",
        "page_idx": 13
    },
    {
        "type": "text",
        "text": "dexamethasone ",
        "page_idx": 13
    },
    {
        "type": "text",
        "text": "4讨论",
        "text_level": 1,
        "page_idx": 14
    },
    {
        "type": "text",
        "text": "文献报道，甾体激素的降解非单一路径，而是形成网络，涉及分泌蛋白与非分泌蛋白共同参与[20]。目前，一些关键基因的功能已被鉴定，德国基尔大学的熊光明教授等[21]报道发现睾丸酮丛毛单胞菌（Comamonas testosteroni，C.T.）中存在3a-羟基类固醇脱氢酶/基还原酶（3a-HSD/CR）基因活性。3a-羟基类固醇脱氢酶/羰基还原酶是一个降解环境中甾体类化合物的关键酶。另有美国学者JulioE.Cabrera[2]报道了3，17β-羟基类固醇脱氢酶基因，其编码的3， $1 7 \\beta$ -HSD 能够降解类固醇激素。Pandey 等[23]发现Mce4操纵子编码的转运蛋白可作用于甾体，是Mtuberculosis摄取宿主胆固醇的关键系统。",
        "page_idx": 14
    },
    {
        "type": "text",
        "text": "本课题前期从B.CQ001全基因组测序中发现有一条已报道的涉及甾体的代谢途径，含有已报道的1个编码与甾类化合物代谢中摄取转运蛋白相关的基因和9 个与甾类化合物代谢关键酶相关的基因[16]。本研究从该菌未知功能的基因中筛选出三个目的基因ORF05499、ORF05827以及ORF06535，通过RT-qPCR 技术验证，也与地塞米松降解有关。这也再次证实甾体激素降解是多基因联合作用的过程。3个基因的预测蛋白分别为过氧化物还原酶、甾酮异构酶、异戊酰辅酶 A脱氢酶，分别负责不同的代谢步骤共同完成地塞米松到小分子的物质代谢转变。其中，基因ORF06535表达上调最为明显，推测为该菌地塞米松降解途径中的一个关键基因，其表达产物异戊酰辅酶A脱氢酶，新近报道与脂质代谢相关[24],在地塞米松降解过程中的具体作用有待进一步探讨。但3个基因均未见涉及甾类化合物代谢及地塞米松代谢的报道，本研究结果扩展了对甾类化合物代谢相关基因的认识，也为进一步构建环境污染地塞米松高效降解菌提供了信息。",
        "page_idx": 14
    },
    {
        "type": "text",
        "text": "B.CQ001驯化后对地塞米松磷酸钠及地塞米松的总降解率可明显提升，但在后期冻存恢复培养过程中也发现其降解能力略有下降，呈现不稳定性。通过质粒转化过表达地塞米松降解关键基因，构建表达菌B.CQ002，HPLC检测显示，表达菌对地塞米松磷酸钠及地塞米松的总降解率可达到 $89 . 0 \\%$ 和 $80 . 0 \\%$ ，其降解能力有一定程度的提升，此结果为后期构建高效、稳定的地塞米松降解工程菌提供了初步实践。",
        "page_idx": 14
    },
    {
        "type": "text",
        "text": "参考文献",
        "text_level": 1,
        "page_idx": 15
    },
    {
        "type": "text",
        "text": "[1] Yabuuchi E, Kosako Y, Oyaizu H, et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group I to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov[J]. Microbiology and immunol0gy, 1992, 36(12): 1251-1275.   \n[2] Lemaire B, Chimphango S B M, Stirton C, et al. Biogeographical patterns of   \nlegume-nodulating Burkholderia spp.: From African fynbos to continental scales[J]. Applied and environmental microbiology,2016, 82(17): 5099-5115.   \n[3] Hamid S,Bae W, Kim S,et al. Enhancing co-metabolic degradation of trichloroethylene with toluene using Burkholderia vietnamiensis G4 encapsulated in polyethylene glycol polymer[J]. Environmental technology,2014,35(12): 1470-1477.   \n[4] 赵奎．地塞米松磷酸钠注射液在急诊应用的处方分析[J]．中国医院用药评价与分析, 2011, 11(5): 475-476. Zhao K. Prescription analysis of Dexamethasone Sodium Phosphate Injection in emergency department [J]. Chinese hospital drug evaluation and analysis,2011,11 (5): 475-476.   \n[5] Takahashi T, Nakamura Y,Tsuya A, et al. Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients[J]. Cancer   \nchemotherapy and pharmacology,2011, 68(3): 653-659.   \n[6] Rathod S S, Motghare VM, Deshmukh V S, et al. Prescribing practices of topical   \ncorticosteroids in the outpatient dermatology department of a rural tertiary care teaching   \nhospital[J]. Indian journal of dermatology, 2013, 58(5): 342.   \n[7] Kim E J,Lee JG, Kim JY, Kim JY, et al. Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.[J]. Immunology, 2017. DOI:   \n10.1111/imm.12804.   \n[8] Mushaben E M, Brandt EB, Hershey G K, et al. Differential effects of rapamycin and dexamethasone in mouse models of established allergic asthma[J]. Plos One,2013,8(1):e54426. [9] Vander Linden SC, Heringa MB,Man HY,et al. Detection of multiple hormonal activities in wastewater effluents and surface water, using a panel of steroid receptor CALUX bioassays. [J]Environ Sci Technol. 2008,42(15):5814-20   \n[10] Schriks M, van Leerdam JA, van der Linden SC,et al. High-resolution mass spectrometric identification and quantification of glucocorticoid compounds in various wastewaters in the Netherlands[J].Environ Sci Technol. 2010,44(12):4766-74.   \n[11] Chang H, Hu J, Shao B.Occurrence of natural and synthetic glucocorticoids in sewage treatment plants and receiving river waters[J].Environ Sci Technol. 2007,41(1O):3462-8.   \n[12]石中全,周裕珍,杨致邦等．废水中地塞米松污染的探讨[J]，中国医药指南。2012,10（9)： 319-321。   \nShi Z Q, Zhou Y Z, Yang Z B, et al. Investigation on the pollution of dexamethasone in wastewater.[J], Chinese Medical Guideline.2012,10 (9):319-321.   \n[13] Takahashi T, Nakamura Y,Tsuya A, et al. Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients[J].Cancer Chemother Pharmacol, 2011,(68):653-659. ",
        "page_idx": 15
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 15
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 15
    },
    {
        "type": "text",
        "text": "[14] 韦英杰，王长梅，蔡雪婷等．地塞米松影响骨骼发育的斑马鱼模型的建立[J]．药学学报, 2013,48(2): 255-260. ",
        "page_idx": 16
    },
    {
        "type": "text",
        "text": "Wei Y J, Wang C M, Cai XT, et al.Establishment of zebrafish model of skeletal development affected by dexamethasone [J]. Journal of pharmacology,2013, 48 (2): 255-260. [15]杨茜，李晓愚，斯丹等．饮水中地塞米松污染对小鼠肠道菌群的影响[J]．南方医科大学 学报,2016,36(2): 238-243. ",
        "page_idx": 16
    },
    {
        "type": "text",
        "text": "Yang Q, Li X Y, S D, et al. Effects of dexamethasone pollution in drinking water on intestinal microflora in mice [J]. Journal of Southern Medical University,2016,36 (2): 238-243. [16] 斯丹，杨致邦，蒋任举等．具有高效降解地塞米松能力的伯克霍尔德菌CQ001株的分离 及功能基因组学分析[J]．第三军医大学学报,2017,39(13):1352-1359. Si D,Yang Z B,Jiang R J, et al. Separation and functional genomics of Burkholderia sp.CQ001 with high degradation ability of dexamethasone [J]. Journal of Third Military Medical University, 2017,39 (13): 1352-1359. [17] Bustin S A, Benes V, Garson JA, et al. The MIQE Guidelines: Minimum information for Publication of quantitative Real-Time PCR experiments[J]. Clinical Chemistry,2009:611-612 [18] 石中全，杨致邦，朱黎黎,等．一株地塞米松磷酸钠降解菌的分离鉴定[J]．中国微生态学 杂志,2014,26(11):1250-1256. Shi Z Q, Yang Z B, Zhu L L, et al. Isolation and identification of a strain of dexamethasone sodium phosphate degradation bacteria [J]. Chinese Journal of microecology, 2014,26 (11): 1250-1256. [19] Zhu L, Yang Z, Qian Y, et al. Degradation of dexamethasone by acclimated strain of Pseudomonas Alcaligenes[J]. International Journal of Clinical & Experimental Medicine, 2015, 8(7):10971. [20] Yao K, Wang F Q, Zhang H C, et al. Identification and engineering of cholesterol oxidases involved in the initial step of sterols catabolism in Mycobacterium neoaurum.[J]. Metabolic Engineering,2013,15(1):75-87. [21] Xiong G,LuoY, Jin S,, et al. Cis- and trans-regulatory elements of 3alpha-hydroxysteroid dehydrogenase/carbonyl reductase as biosensor system for steroid determination in the environment[J]. Chemico-Biological Interactions,2009,178(3):215-220. [22] Torchilin VP,Narula J, Halpern E, et al.Poly (ethylene glycol)-coated anti-cardiac myosin immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium[J]. Biochimica et Biophysica Acta (BBA)-Biomembranes,1996, 1279(1): 75-83. [23] Pandey A K, Sassetti C M. Mycobacterial persistence requires the utilization of host cholesterol[J]. Proceedings of the National Academy of Sciences,2008,105(11): 4376-4380. [24] Bloem A, Sanchez I, Dequin S,et al. Metabolic impact of redox cofactor perturbations on the formation of aroma compounds in Saccharomyces cerevisiae[J]. Applied and environmental microbiology, 2015: AEM. 02429-15. ",
        "page_idx": 16
    }
]